Iterative Metal Artifact Reduction in Head and Neck CT Facilitates Tumor Visualization of Oral and Oropharyngeal Cancer Obscured by Artifacts From Dental Hardware.
Artifact
Cancer imaging
Computed tomography
Head and neck
Metal artifact reduction
Journal
Academic radiology
ISSN: 1878-4046
Titre abrégé: Acad Radiol
Pays: United States
ID NLM: 9440159
Informations de publication
Date de publication:
12 2023
12 2023
Historique:
received:
08
02
2023
revised:
02
04
2023
accepted:
07
04
2023
medline:
1
12
2023
pubmed:
14
5
2023
entrez:
13
5
2023
Statut:
ppublish
Résumé
The purpose of this study was to evaluate the diagnostic utility of iterative metal artifact reduction (iMAR) in computed tomography (CT)-imaging of oral and oropharyngeal cancers when obscured by dental hardware artifacts and to determine the most appropriate iMAR settings for this purpose. The study retrospectively enrolled 27 patients (8 female, 19 male; mean age 64±12.7years) with histologically confirmed oral or oropharyngeal cancer obscured by dental artifacts in contrast-enhanced CT. Raw CT data were reconstructed with ascending iMAR strengths (levels 1/2/3/4/5) and one reconstruction without iMAR (level 0). For subjective analysis, two blinded radiologists rated tumor visualization and artifact severity on a five-point Likert scale. For objective analysis, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and artifact index (AI) were determined. iMAR reconstructions improved the subjective image quality of tumor edge and contrast, and the objective parameters of tumor SNR and CNR, reaching their optimum at iMAR levels 4 and 5 (P<.001). AI decreased with iMAR reconstructions reaching its minimum at iMAR level 5 (P<.001). Tumor detection rates increased 2.4-fold with iMAR 5, 2.1-fold with iMAR 4, and 1.9-fold with iMAR 3 compared to reconstructions without iMAR. Disadvantages such as algorithm-induced artifacts increased significantly with higher iMAR strengths (P<.05), reaching a maximum with iMAR 5. iMAR significantly improves CT imaging of oral and oropharyngeal cancers, as confirmed by both subjective and objective measures, with best results at highest iMAR strengths.
Identifiants
pubmed: 37179206
pii: S1076-6332(23)00199-X
doi: 10.1016/j.acra.2023.04.007
pii:
doi:
Substances chimiques
Metals
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2962-2972Informations de copyright
Copyright © 2023 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Matthias Stefan May reports a relationship with Siemens Healthcare that includes: speaking and lecture fees. Wolfgang Wuest reports a relationship with Siemens Healthcare that includes: speaking and lecture fees. Jan-Peter Roth reports a relationship with Siemens Healthcare that includes: speaking and lecture fees. Michael Uder reports a relationship with Siemens Healthcare that includes: speaking and lecture fees. Christian Hofmann reports a relationship with Siemens Healthcare that includes: employment. Bernhard Schmidt reports a relationship with Siemens Healthcare that includes: employment.